Prosecution Insights
Last updated: November 20, 2026

Kapa Biosystems Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Kapa Biosystems Inc. is currently navigating 2 pending office actions within the Chemistry & Materials technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units, showing a diverse spread of examination environments for the company's current filings. This distribution suggests that the pending applications cover different technical sub-specialties within the chemistry field. Managing 2 separate art units requires a flexible approach to prosecution. The applicant must be prepared to address the specific technical standards of each of the 2 distinct art units involved.

Examiner GAMBLE JR, RANDALL LEE is identified as the busiest examiner for the portfolio, currently managing 1 pending office action. Since each of the 2 distinct examiners is handling exactly 1 of the 2 pending actions, the workload is evenly split. This lack of concentration across the 2 art units requires the applicant to adapt to different examiner styles and procedural preferences for each of the pending matters. Practitioners should treat each of the 2 pending office actions as independent efforts with little examiner-level overlap. Successfully navigating the 1 pending office action with the busiest examiner will be a key milestone for the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHANG, KAIJIANG 1 77.2% +34.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17813364 SYSTEM AND METHOD FOR NUCLEIC ACID LIBRARY PREPARATION VIA TEMPLATE SWITCHING MECHANISM ZHANG, KAIJIANG 15d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17813364 SYSTEM AND METHOD FOR NUCLEIC ACID LIBRARY PREPARATION VIA TEMPLATE SWITCHING MECHANISM ZHANG, KAIJIANG 15d

Top Art Units

Art UnitApps
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17813364 SYSTEM AND METHOD FOR NUCLEIC ACID LIBRARY PREPARATION VIA TEMPLATE SWITCHING MECHANISM ZHANG, KAIJIANG 1684 §102§103 Non-Final OA 15d Pending Jul 19, 2022

Managing Kapa Biosystems Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Kapa Biosystems Inc. have?

Kapa Biosystems Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Kapa Biosystems Inc. applications?

Kaijiang Zhang has the most, with 1 of Kapa Biosystems Inc.'s pending office actions.

What technology area are Kapa Biosystems Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month